| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.23B | +14.4% |
| Cost of Revenue | $2.50B | +14.7% |
| Gross Profit | $736.0M | +13.6% |
| R&D Expense | $92.0M | +12.2% |
| SG&A Expense | $414.0M | +7.8% |
| Operating Income | $293.0M | +26.8% |
| Pre-tax Income | $264.0M | +37.5% |
| Income Tax | $51.0M | +112.5% |
| Net Income | $213.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $598.0M | +28.1% |
| Accounts Receivable | $253.0M | +67.5% |
| Inventory | $358.0M | +8.8% |
| Current Assets | $2.16B | +12.8% |
| Total Assets | $4.18B | +6.7% |
| Current Liabilities | $1.12B | +3.5% |
| Long-term Debt | $366.0M | -10.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $271.0M | +32.2% |
| Capital Expenditures | $85.0M | +41.7% |
| Investing Cash Flow | -$84.0M | -42.4% |
| Financing Cash Flow | -$56.0M | -473.3% |
| Free Cash Flow | $186.0M | +28.3% |
| +26.8% |
| EPS (Basic) | $0.81 | +26.6% |
| EPS (Diluted) | $0.80 | +25.0% |
| Stockholders' Equity |
| $2.56B |
| +10.0% |